InsidersTradesSigma
Track the HUTCHMED (China) Ltd. stock price and the full management transaction log of the company, a listed issuer based in Hong Kong. Shares trade on HK HK, under the oversight of HKEX. The latest transaction was filed on 22 May 2026 (Purchase). Among the most active insiders: CHENG Chig Fung Johnny. All data is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
HUTCHMED (China) Ltd. is a biopharmaceutical company focused on the research and development of drugs for cancer treatment and immune-related diseases. It is based in China and also operates internationally.